Venture Capital 101: Featuring Frank T. Gentile, PhD, Venture Partner at Third Rock Ventures

What is venture capital in the life sciences and what is it like to work in that space? Join us for a discussion of venture capital in the life sciences followed by a Q&A session.

WHEN: Tuesday, March 21 at 5-6:30 pm

WHERE: Cannon Room, Building C, Harvard Medical School

Dinner will be provided.


Dr. Frank Gentile joined Third Rock Ventures in 2015 to focus on research and development opportunities throughout the portfolio. He brings nearly 25 years of experience working with pharmaceutical and biotechnology companies to oversee and execute biotechnology and healthcare investments in public and private companies.

Third Rock Ventures is a premier life sciences venture capital firm. With over $1.3 billion raised since it started in 2007, Third Rock Ventures has assembled an entrepreneurial team with deep expertise and a proven track record of building some of the most respected and successful life sciences companies.